Objectives Clinicians learn from prior adverse events through pharmacovigilance allowing
for improved medication safety in the medication use process; therefore, adverse drug …

Background: Adverse drug reactions (ADRs) are a significant cause of morbidity and
mortality, with many being identified post-marketing. Improvement in current ADR reporting …

Aim The aim of the present study was to determine the barriers and motives influencing
consumer reporting of adverse drug reactions (ADRs). Methods A systematic review, guided …

Background Various strategies have been studied in the literature to address the significant
underreporting of adverse drug reactions (ADRs) in healthcare systems worldwide …

Importance/Objective: Adverse Drug Reactions (ADRs) are unavoidable, but recognizing
and addressing ADRs early can improve wellness and prevent permanent injury. We …

Objective: Using a patient targeted survey, we sought to assess patient representations of
how physicians responded when patients presented with possible adverse drug reactions …

Background Monitoring adverse drug reactions (ADRs) through pharmacovigilance are vital
to patient safety. Spontaneous ADR reporting is one method of pharmacovigilance, and in …

When a new medical product is released to the market, a continuous pharmacovigilance
process is initiated to guarantee patient safety by collecting and analyzing adverse drug …

Aims To synthesize data from published studies and international experience to identify
evidence of potential benefits and drawbacks of direct patient reporting of suspected …

Background Spontaneous reporting of adverse drug reactions (ADRs) is an important
source of information for post-marketing drug safety evaluation. Most countries have public …